The TCGA project’s analysis, encompassing data from 31 cancer types, shows that TRPA1 is significantly overexpressed in cancers with different origins, such as kidney cancer, breast cancer, cholangiocarcinoma, head and neck squamous cell carcinoma, and lung, prostate and thyroid cancers. This evidence concerns the gene TRPA1 and cholangiocarcinoma.